biotech

While not everyone in the IR profession will be working in the environment that biotech IROs find themselves in today, everyone seemingly everywhere is battling the noise and uncertainty generated by tariff talks, geopolitical tensions and other macro headwinds. IR Impact recently sat down with Angela Bitting, senior vice president, corporate affairs at Twist Bioscience, Aron Feingold, vice president IR and corporate communications at Geron Corporation and Lynn Pieper Lewis, founder and CEO of webinar sponsor Gilmartin Group, to talk about the challenges the sector is facing. The fascinating discussion that followed is as useful to those in the broader…